Skip to content

Study on the Effect of Takeaway Packaging Exposure on New-Onset Type 2 Diabetes in Young Adults

Study on the impact of exposure to endocrine disruptors on new-onset young-onset type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127404
Enrollment
Unknown
Registered
2026-06-30
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Case group:Implement a 12-month diabetes specialist nurse-led nutrition education intervention, combined with EDCs exposure prevention and takeout diet adjustments, to create a standardized interventi
Control group:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–40 years inclusive; 2. Diagnosed with type 2 diabetes mellitus (T2DM) in accordance with the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2022 Edition), with first diagnosis confirmed within the preceding 6 months. Diagnostic criteria: fasting blood glucose >=7.0 mmol/L, or 2-hour postprandial blood glucose >=11.1 mmol/L, or random blood glucose >=11.1 mmol/L accompanied by diabetic symptoms; asymptomatic subjects require repeated testing for confirmation; 3. Absence of other types of diabetes (e.g., type 1 diabetes mellitus, gestational diabetes mellitus, secondary diabetes); 4. Free from severe organic diseases including severe hepatic or renal failure, malignant tumors, autoimmune diseases, cardiovascular and cerebrovascular diseases; 5. No standardized dietary, exercise or pharmacological interventions for diabetes received in the latest 3 months; 6. Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Participants with a prior history of diabetes or previous hypoglycemic treatment; 2. Those under stress conditions such as acute infection, surgery or trauma within the latest 3 months; 3. Individuals taking long-term medications that may affect endocrine function (e.g., glucocorticoids, oral contraceptives); 4. Patients with psychiatric disorders or cognitive impairment unable to complete questionnaires, specimen collection and intervention; 5. Subjects with poor anticipated compliance or high risk of severe loss to follow-up during follow-up; 6. Persons with confirmed occupational exposure to environmental endocrine-disrupting chemicals (EDCs), including workers in chemical industry, pesticide production, plastic processing and related sectors; 7. Vulnerable populations: patients with mental illness, cognitive dysfunction, critically ill patients, pregnant women and illiterate individuals.

Design outcomes

Primary

MeasureTime frame
Blood Glucose;

Countries

China

Contacts

Public Contactweiying xu

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

xuwy@srrsh.com+86 571 86002560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026